Literature DB >> 16439998

cGMP signalling: from bench to bedside. Conference on cGMP generators, effectors and therapeutic implications.

Robert Feil1, Barbara Kemp-Harper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16439998      PMCID： PMC1369255          DOI： 10.1038/sj.embor.7400627

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  15 in total

1.  Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase.

Authors:  Peter M Schmidt; Matthias Schramm; Henning Schröder; Frank Wunder; Johannes-Peter Stasch
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

Review 2.  B-type natriuretic peptide as a biomarker beyond heart failure: speculations and opportunities.

Authors:  Paul M McKie; John C Burnett
Journal:  Mayo Clin Proc       Date:  2005-08       Impact factor: 7.616

3.  Membrane association of nitric oxide-sensitive guanylyl cyclase in cardiomyocytes.

Authors:  Luis Agulló; David Garcia-Dorado; Noelia Escalona; Marisol Ruiz-Meana; Maribel Mirabet; Javier Inserte; Jordi Soler-Soler
Journal:  Cardiovasc Res       Date:  2005-10-01       Impact factor: 10.787

4.  Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.

Authors:  Eiki Takimoto; Hunter C Champion; Manxiang Li; Diego Belardi; Shuxun Ren; E Rene Rodriguez; Djahida Bedja; Kathleen L Gabrielson; Yibin Wang; David A Kass
Journal:  Nat Med       Date:  2005-01-23       Impact factor: 53.440

5.  Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide.

Authors:  Karim Sabrane; Markus N Kruse; Larissa Fabritz; Bernd Zetsche; Danuta Mitko; Boris V Skryabin; Melanie Zwiener; Hideo A Baba; Masashi Yanagisawa; Michaela Kuhn
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

6.  IRAG is essential for relaxation of receptor-triggered smooth muscle contraction by cGMP kinase.

Authors:  Angela Geiselhöringer; Matthias Werner; Katja Sigl; Petra Smital; René Wörner; Linda Acheo; Juliane Stieber; Pascal Weinmeister; Robert Feil; Susanne Feil; Jörg Wegener; Franz Hofmann; Jens Schlossmann
Journal:  EMBO J       Date:  2004-10-14       Impact factor: 11.598

7.  Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice.

Authors:  Steffen Massberg; Sabine Grüner; Ildiko Konrad; Maisa I Garcia Arguinzonis; Martin Eigenthaler; Kathrin Hemler; Julia Kersting; Christian Schulz; Iris Muller; Felicitas Besta; Bernhard Nieswandt; Ulrich Heinzmann; Ulrich Walter; Meinrad Gawaz
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

Review 8.  Cyclic GMP phosphodiesterases and regulation of smooth muscle function.

Authors:  Sergei D Rybalkin; Chen Yan; Karin E Bornfeldt; Joseph A Beavo
Journal:  Circ Res       Date:  2003-08-22       Impact factor: 17.367

Review 9.  Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A.

Authors:  Michaela Kuhn
Journal:  Circ Res       Date:  2003-10-17       Impact factor: 17.367

10.  Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.

Authors:  Oleg V Evgenov; Fumito Ichinose; Natalia V Evgenov; Mark J Gnoth; George E Falkowski; Yuchiao Chang; Kenneth D Bloch; Warren M Zapol
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690
View more
  23 in total

Review 1.  Soluble guanylate cyclase modulators in heart failure.

Authors:  Veselin Mitrovic; Ana Jovanovic; Stefan Lehinant
Journal:  Curr Heart Fail Rep       Date:  2011-03

2.  cGMP-Prkg1 signaling and Pde5 inhibition shelter cochlear hair cells and hearing function.

Authors:  Mirko Jaumann; Juliane Dettling; Martin Gubelt; Ulrike Zimmermann; Andrea Gerling; François Paquet-Durand; Susanne Feil; Stephan Wolpert; Christoph Franz; Ksenya Varakina; Hao Xiong; Niels Brandt; Stephanie Kuhn; Hyun-Soon Geisler; Karin Rohbock; Peter Ruth; Jens Schlossmann; Joachim Hütter; Peter Sandner; Robert Feil; Jutta Engel; Marlies Knipper; Lukas Rüttiger
Journal:  Nat Med       Date:  2012-01-22       Impact factor: 53.440

Review 3.  Role of guanylate cyclase modulators in decompensated heart failure.

Authors:  Veselin Mitrovic; Adrian F Hernandez; Markus Meyer; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2009-12       Impact factor: 4.214

4.  Genetic variation at the coronary artery disease risk locus GUCY1A3 modifies cardiovascular disease prevention effects of aspirin.

Authors:  Kathryn T Hall; Thorsten Kessler; Julie E Buring; Dani Passow; Howard D Sesso; Robert Y L Zee; Paul M Ridker; Daniel I Chasman; Heribert Schunkert
Journal:  Eur Heart J       Date:  2019-11-01       Impact factor: 29.983

Review 5.  Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease.

Authors:  Jan R Kraehling; William C Sessa
Journal:  Circ Res       Date:  2017-03-31       Impact factor: 17.367

Review 6.  [Genetic testing in polygenic diseases : Atrial fibrillation, arterial hypertension and coronary artery disease].

Authors:  T Trenkwalder; T Kessler; H Schunkert
Journal:  Herz       Date:  2017-08       Impact factor: 1.443

Review 7.  Carbon monoxide--physiology, detection and controlled release.

Authors:  Stefan H Heinemann; Toshinori Hoshi; Matthias Westerhausen; Alexander Schiller
Journal:  Chem Commun (Camb)       Date:  2014-04-11       Impact factor: 6.222

8.  Novel Therapeutics: NSAIDs, Derivatives, and Phosphodiesterases.

Authors:  Heather N Tinsley; Gary A Piazza
Journal:  Curr Colorectal Cancer Rep       Date:  2012-12

9.  Clathrin-dependent internalization, signaling, and metabolic processing of guanylyl cyclase/natriuretic peptide receptor-A.

Authors:  Naveen K Somanna; Indra Mani; Satyabha Tripathi; Kailash N Pandey
Journal:  Mol Cell Biochem       Date:  2017-09-12       Impact factor: 3.396

10.  Inhibition of soluble guanylyl cyclase by small molecules targeting the catalytic domain.

Authors:  Jagamya Vijayaraghavan; Kristopher Kramp; Michael E Harris; Focco van den Akker
Journal:  FEBS Lett       Date:  2016-10-04       Impact factor: 4.124
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.